Lyell Immunopharma shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $11k | 17k | 0.64 |
| 2024-09-30 | $24k | 17k | 1.38 |
| 2024-06-30 | $25k | 17k | 1.45 |
| 2024-03-31 | $38k | 17k | 2.23 |
| 2023-12-31 | $33k | 17k | 1.94 |
| 2023-09-30 | $25k | 17k | 1.47 |
| 2023-06-30 | $41k | 13k | 3.18 |
| 2023-03-31 | $31k | 13k | 2.36 |
| 2022-12-31 | $39k | 13k | 2.98 |
| 2022-09-30 | $95k | 13k | 7.32 |
| 2022-06-30 | $84k | 13k | 6.47 |
| 2022-03-31 | $58k | 12k | 5.04 |
| 2021-12-31 | $14k | 1.8k | 7.73 |
| 2021-09-30 | $27k | 1.8k | 14.91 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors